This page includes the latest FDA filings for Nalpropion Pharmaceuticals Inc. Currently, you will find the latest 100 filings for Premarket Notifications, Premarket Applications, De Novo Applications, and GUDID registrations.
Device Company | Device | Date |
---|---|---|
Nalpropion Pharmaceuticals LLC | Prescription Medication | 2025-05-11 |
Nalpropion Pharmaceuticals LLC | Prescription Medication | 2024-05-31 |
Nalpropion Pharmaceuticals LLC | Prescription Medication | 2023-12-21 |
Nalpropion Pharmaceuticals LLC | Prescription Medication | 2023-04-06 |
Nalpropion Pharmaceuticals LLC | Prescription Medication | 2023-01-26 |
Nalpropion Pharmaceuticals LLC | Prescription Medication | 2021-11-06 |
Nalpropion Pharmaceuticals LLC | Prescription Medication | 2021-03-16 |
Nalpropion Pharmaceuticals LLC | Prescription Medication | 2020-11-06 |
Nalpropion Pharmaceuticals LLC | Prescription Medication | 2020-08-14 |
Nalpropion Pharmaceuticals LLC | Prescription Medication | 2019-04-30 |
Nalpropion Pharmaceuticals, Inc. | Contrave | 2014-10-22 |
NCAGE Code | 89HB0 | NALPROPION PHARMACEUTICALS, INC. |
S.A.M. Registration | 89HB0 [81341086] | NALPROPION PHARMACEUTICALS, INC. |
S.A.M. Registration | 89HB0 [81341086] | NALPROPION PHARMACEUTICALS, INC. |
DUNS | 081341086 | Nalpropion Pharmaceuticals, Inc. |